Devyser’s NGS products for monitoring of kidney and stem cell transplant patients receive IVDR approvals
Devyser’s novel test for detecting donor-derived cell-free DNA in blood samples from...
Detect graft rejection and disease relapse in stem cell transplant patients at a very early stage with an advanced, single-tube chimerism testing solution. In collaboration with Thermo Fisher Scientific, this product is now available as One Lambda™ Devyser Chimerism NGS in the USA, Canada, and Europe.
Quickly detect graft rejection, disease relapse and minimal residual disease by tight monitoring
45
Reduce hands-on time, below 45 minutes
0.05
High precision and sensitivity down to >0.05 percent
The dd-cfDNA assay is a high-precision test solution for very early detection of graft rejection and disease relapse in stem cell transplant patients. It quickly detects microchimerism, graft rejection and any minimal residual disease. Requiring less than 45 minutes of hands-on time, the easy-to-use kit is designed for maximum lab efficiency and a fast and repeatable workflow, from patient sample to report. Screening samples are sequenced only once, saving time and increasing lab productivity. A single workflow for both screening and monitoring eliminates the need for sample-specific primers and patient-specific marker tracking. A single universal reagent mix for all patients also helps reduce reagent wastage and the need to keep multiple reagents in stock.
Results are highly accurate, with possible measurement of sensitivity to >0.05 percent. This is facilitated by combining the sensitive analysis of real-time PCR with precise measurements at high chimerism levels using STR fragment analysis. One tube per sample avoids any need for sample splitting. The single measurement method is independent of mixed chimerism levels, allowing true detection and monitoring of micro chimerism.
It is an end-to-end solution with dedicated software for fast, accurate result analysis. It reduces laboratory processing costs by ensuring targeted sequencing with high uniformity and by maximizing sample capacity on every next-generation sequence flow cell.
You are on this page because of an exclusive collaboration and distribution agreement between Devyser and Thermo Fisher Scientific.
Instructions for use
Enter access code found in the lower right corner of the label on the kit box.
Certificates
Download a specific Batch Release Certificate (BRC) below.
Guidelines and handbooks (2)
Product information (0)
Software settings (5)
Safety data sheets (1)
Data tables (0)
Enter access code found in the lower right corner of the label on the kit box.
Download a specific Batch Release Certificate (BRC) below.
RUO
One Lambda Devyser Chimerism NGS
Screening and monitoring of mixed chimerism
8-A411-24
8-A411-48
Pack size: 24
Pack size: 48
CE-IVDR
One Lambda Devyser Chimerism NGS
Screening and monitoring of mixed chimerism
8-R107-24
8-R107-48
Pack size: 24
Pack size: 48
Devyser’s novel test for detecting donor-derived cell-free DNA in blood samples from...
Read More
A better patient care is the final objective for Dr. Helena Devos and the team at Sint Jan’s...
Read More
Collaboration and distribution agreement with Thermo Fisher Scientific Thermo Fisher Scientific...
Read More
As a lab manager, you know the importance of streamlining workflows to maximize productivity and...
Read More